The Cystic Fibrosis Foundation has agreed to provide Prime Medicine Inc. an additional investment of up to $24 million to ...

Alfie Coe, 13, from Terrington St Clement, will be running 3km daily during his school summer holidays to raise money for the ...

The two companies will scale production for a novel recombinant version of alpha-1 antitrypsin targeting lung diseases.

Vertex Pharmaceuticals has announced a reimbursement agreement with NHS England for its cystic fibrosis (CF) medicine, Alyftrek.

US biotech major Vertex Pharmaceuticals (Nasdaq: VRTX) has reached a wide-ranging reimbursement deal with NHS England for ...

Children and adults with rare forms of cystic fibrosis in England will be able to access triple-combination therapy. Vanzacaftor–tezacaftor–deutivacaftor (Alyftrek®), is the latest in a new generation ...

Licensed for use in the UK in March, Alyftrek will now be immediately funded by the NHS in England. This rapid timeline demonstrates NICE's commitment to getting breakthrough treatments to patients ...

Latest studies show Us pharma giant Vertex's new CF wonder pill Alyftrek has shown better results than their currently available drug Kaftrio.

Autonomy, confidence and competence were stronger predictors of wellbeing than more traditional measures like deprivation or ...

A Ph.D. graduate student in biomolecular engineering at UC Santa Cruz, with a background in computer science and mathematics, ...

Dominion Energy is the kind of stable utility stock that's great to own during turbulent markets. Enbridge has a lower risk ...

Charles Kim Haskell told Newsweek he once thought he wouldn't live beyond his teenage years, but, at 31, he is enjoying his life.